USD 30.3
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2024 | 191.71 Billion USD | 42.62% |
2023 | 153.13 Million USD | 29.51% |
2022 | 118.24 Million USD | 65.48% |
2021 | 71.45 Million USD | -72.66% |
2020 | 261.34 Million USD | -4.23% |
2019 | 272.89 Million USD | 54.2% |
2018 | 176.97 Million USD | -7.46% |
2017 | 191.23 Million USD | -25.78% |
2016 | 257.66 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 23.15 Million USD | 53.02% |
2024 FY | 191.7 Million USD | 25.19% |
2024 Q3 | 68.12 Million USD | -23.35% |
2024 Q4 | 23.25 Million USD | -63.39% |
2024 Q2 | 83.92 Million USD | 275.28% |
2023 FY | 153.13 Million USD | 29.51% |
2023 Q2 | 56.42 Million USD | 185.9% |
2023 Q1 | 19.73 Million USD | 109.08% |
2023 Q3 | 55.73 Million USD | -1.21% |
2023 Q4 | 16.44 Million USD | -70.49% |
2022 Q2 | 86.32 Million USD | 2323.08% |
2022 FY | 118.24 Million USD | 65.48% |
2022 Q4 | 9.43 Million USD | -73.28% |
2022 Q3 | 35.32 Million USD | -59.08% |
2022 Q1 | -3.88 Million USD | -123.99% |
2021 FY | 71.45 Million USD | -72.66% |
2021 Q4 | 16.19 Million USD | 0.0% |
2020 FY | 261.34 Million USD | -4.23% |
2019 FY | 272.89 Million USD | 54.2% |
2018 FY | 176.97 Million USD | -7.46% |
2017 FY | 191.23 Million USD | -25.78% |
2016 FY | 257.66 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
China Medicine Corporation | 1.71 Million USD | -11161170.134% |
DH Enchantment Inc. | -156.15 Thousand USD | 122773642.615% |
Exlites Holdings International, Inc. | -90.49 Thousand USD | 211855790.495% |
Itonis, Inc. | -38.31 Thousand USD | 500390489.685% |
One Step Vending Corp. | -27.79 Thousand USD | 689869009.68% |
MediPal Holdings Corporation | 274.02 Million USD | -69862.355% |
PD-Rx Pharmaceuticals, Inc. | -98.06 Thousand USD | 195499539.142% |
Pharmagen, Inc. | -6457.61 USD | 2968816271.927% |